
    
      This is a single-arm, single center, phase II trial to investigate the feasibility and
      toxicity of tomotherapy for refractory brain metastases, which are defined as A: multiple
      brain metastases(â‰¥3 lesions); B: large brain metastases(with one lesion's volume is no
      smaller than 6cc or the longest diameter is no shorter than 3cm); C: meningeal metastases.
    
  